Product Images Flucelvax Quadrivalent

View Photos of Packaging, Labels & Appearance

Product Label Images

The following 4 images provide visual information about the product associated with Flucelvax Quadrivalent NDC 70461-323 by Seqirus Inc., such as packaging, labeling, and the appearance of the drug itself. This resource could be helpful for medical professionals, pharmacists, and patients seeking to verify medication information and ensure they have the correct product.

Principal Display Panel – 5 mL Carton Label - flu2l 0006 01

Principal Display Panel – 5 mL Carton Label - flu2l 0006 01

This is a description of Influenza Vaccine FLUCELVAX, Quadrivalent for the 2022-2023 formula. The vaccine is prepared using cells from MDCK and inactivated with BPL. The manufacturing company is Seqirus Inc. located in Holly Springs, NC, and the vaccine is distributed by Seqirus USA Inc. The vaccine is recommended for individuals aged six months and above and is administered through intramuscular injection. Each 0.5 mL dose contains a 15 mcg hemagglutinin of each tan, along with trace amounts of cetytrimethylammonium bromide and beta-propiolactone. The vaccine contains thimerosal as a preservative, which is a mercury derivative at a concentration of 25 mcg mercury per dose. The prescribing information should be consulted for dosage guidelines. The vaccine should be stored between 2-8°C, not frozen, and protected from light.*

Principal Display Panel – 5 mL Vial Label - flu2l 0006 02

Principal Display Panel – 5 mL Vial Label - flu2l 0006 02

This is a description of Influenza Va Quadrivalent vaccine for the Formula year 2022-2023. It is a multi-dose vial with a recommended dosage of 0.5 mL for individuals 6 months of age and older. The vaccine needs to be stored between 2-8°C, and it should not be frozen. It is manufactured by Segirus Inc. in Holly Springs, NC and distributed by Seqirus USA Inc. in Summit, NJ. The US License No. for this vaccine is 2049.*

Principal Display Panel – 0.5 mL Carton Label - flu2l 0006 03

Principal Display Panel – 0.5 mL Carton Label - flu2l 0006 03

This is a description of an influenza vaccine called "Flucelvax Quadrivalent". The vaccine contains four strains of the influenza virus and is administered through intramuscular injection. It is recommended for use in individuals who are 6 months of age and older. The vaccine is stored between 2-8°C (36-46°F), and should be protected from light. The manufacturing process includes the use of beta-propiolactone (BPL), polysorbate 80, cetyltrimethylammonium bromide (CTAB), and Madin Darby Canine Kidney (MDCK) cells. There may be trace amounts of these materials in the final vaccine. The vaccine is distributed by Seqirus USA Inc. and manufactured by Seqirus Inc. in Holly Springs, NC, USA. Prescribing information should be consulted for additional details.*

Principal Display Panel – 0.5 mL Syringe Label - flu2l 0006 04

Principal Display Panel – 0.5 mL Syringe Label - flu2l 0006 04

FLUCELVAX QUADRIVALENT is an influenza vaccine manufactured by Seqirus Inc. Holly Springs for use in people aged 6 months and older in the USA. The Lot number for the 2022-2023 Formula is not readable from the given text.*

* The product label images have been analyzed using a combination of traditional computing and machine learning techniques. It should be noted that the descriptions provided may not be entirely accurate as they are experimental in nature. Use the information in this page at your own discretion and risk.